Target intelligence / Profile preview

T cell receptor alpha joining 9 (TRAJ9)

Target
TRAJ9
Molecular classification
Other
01

Overview

T cell receptor alpha joining 9 (TRAJ9) is a short segment of DNA found on chromosome 14 that encodes the joining (J) region used in the assembly of the T cell receptor alpha (TRA) chain[4]. This region participates in somatic recombination, where it is joined with variable (V) gene segments (such as TRAV9-1 or TRAV9-2) and a constant (C) gene segment to generate the gene encoding the alpha chain of the T cell receptor[2][3][4]. TRAJ9 itself does not encode a standalone functional protein, enzyme, or receptor, but rather serves as a recombinatorial element in building T cell receptor diversity[3]. It is not considered a therapeutic target, and TRAJ9 mutations or characteristics are not directly associated with therapeutic strategies, biomarkers, or disease mechanisms. **Key point:** TRAJ9 is one of many joining segments essential for the diversity of the antigen-recognizing α-chain of the T cell receptor, but it is not itself a receptor, drug target, nor directly involved in disease roles or therapeutic mechanisms[3][4].

Other names
TRAJ9
02

Biological functions

Encodes joining (J) region for T cell receptor alpha chain assemblyParticipates in somatic recombination for TCR diversity

Beyond the preview

Go deeper on T cell receptor alpha joining 9 (TRAJ9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor alpha joining 9 (TRAJ9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call